<?xml version='1.0' encoding='utf-8'?>
<document id="23907716"><sentence text="Co-medication of pravastatin and paroxetine-a categorical study."><entity charOffset="17-28" id="DDI-PubMed.23907716.s1.e0" text="pravastatin" /><entity charOffset="33-43" id="DDI-PubMed.23907716.s1.e1" text="paroxetine" /><pair ddi="false" e1="DDI-PubMed.23907716.s1.e0" e2="DDI-PubMed.23907716.s1.e0" /><pair ddi="false" e1="DDI-PubMed.23907716.s1.e0" e2="DDI-PubMed.23907716.s1.e1" /></sentence><sentence text="Electronic Medical Records (EMRs) are wealthy storehouses of patient information, to which data mining techniques can be prudently applied to reveal clinically significant patterns" /><sentence text=" Detecting patterns in drug-drug interactions, leading to adverse drug reactions is a powerful application of EMR data mining" /><sentence text=" Adverse effects of drug treatments can be investigated by mining clinical laboratory tests data which are reliable indicators of abnormal physiological functions" /><sentence text=" We report here the co-medication effects of pravastatin (HMG-CoA reductase inhibitor) and paroxetine (selective serotonin reuptake inhibitor (SSRI) anti-depressant) on significant clinical parameters, identified through a data mining analysis conducted on the Allscripts data warehouse"><entity charOffset="45-56" id="DDI-PubMed.23907716.s5.e0" text="pravastatin" /><entity charOffset="91-101" id="DDI-PubMed.23907716.s5.e1" text="paroxetine" /><entity charOffset="113-122" id="DDI-PubMed.23907716.s5.e2" text="serotonin" /><pair ddi="false" e1="DDI-PubMed.23907716.s5.e0" e2="DDI-PubMed.23907716.s5.e0" /><pair ddi="false" e1="DDI-PubMed.23907716.s5.e0" e2="DDI-PubMed.23907716.s5.e1" /><pair ddi="false" e1="DDI-PubMed.23907716.s5.e0" e2="DDI-PubMed.23907716.s5.e2" /><pair ddi="false" e1="DDI-PubMed.23907716.s5.e1" e2="DDI-PubMed.23907716.s5.e1" /><pair ddi="false" e1="DDI-PubMed.23907716.s5.e1" e2="DDI-PubMed.23907716.s5.e2" /></sentence><sentence text=" We found that the concomitant drug treatments of pravastatin and paroxetine increased the mean values of glucose serum from 113"><entity charOffset="50-61" id="DDI-PubMed.23907716.s6.e0" text="pravastatin" /><entity charOffset="66-76" id="DDI-PubMed.23907716.s6.e1" text="paroxetine" /><entity charOffset="106-113" id="DDI-PubMed.23907716.s6.e2" text="glucose" /><pair ddi="false" e1="DDI-PubMed.23907716.s6.e0" e2="DDI-PubMed.23907716.s6.e0" /><pair ddi="false" e1="DDI-PubMed.23907716.s6.e0" e2="DDI-PubMed.23907716.s6.e1" /><pair ddi="false" e1="DDI-PubMed.23907716.s6.e0" e2="DDI-PubMed.23907716.s6.e2" /><pair ddi="false" e1="DDI-PubMed.23907716.s6.e1" e2="DDI-PubMed.23907716.s6.e1" /><pair ddi="false" e1="DDI-PubMed.23907716.s6.e1" e2="DDI-PubMed.23907716.s6.e2" /></sentence><sentence text="2 to 132" /><sentence text="1 mg/dL and international normalized ratio (INR) from 2" /><sentence text="18 to 2" /><sentence text="52, respectively" /><sentence text=" It also decreased the mean values of estimated glomerular filtration rate (eGFR) from 43 to 37 mL/min/1" /><sentence text="73 m(3) and blood CO2 levels from 24"><entity charOffset="18-21" id="DDI-PubMed.23907716.s12.e0" text="CO2" /></sentence><sentence text="8 to 23" /><sentence text="9 mEq/L respectively" /><sentence text=" Our findings indicate that co-medication of pravastatin and paroxetine might have significant impact on blood anti-coagulation, kidney function, and glucose homeostasis"><entity charOffset="45-56" id="DDI-PubMed.23907716.s15.e0" text="pravastatin" /><entity charOffset="61-71" id="DDI-PubMed.23907716.s15.e1" text="paroxetine" /><entity charOffset="150-157" id="DDI-PubMed.23907716.s15.e2" text="glucose" /><pair ddi="false" e1="DDI-PubMed.23907716.s15.e0" e2="DDI-PubMed.23907716.s15.e0" /><pair ddi="false" e1="DDI-PubMed.23907716.s15.e0" e2="DDI-PubMed.23907716.s15.e1" /><pair ddi="false" e1="DDI-PubMed.23907716.s15.e0" e2="DDI-PubMed.23907716.s15.e2" /><pair ddi="false" e1="DDI-PubMed.23907716.s15.e1" e2="DDI-PubMed.23907716.s15.e1" /><pair ddi="false" e1="DDI-PubMed.23907716.s15.e1" e2="DDI-PubMed.23907716.s15.e2" /></sentence><sentence text=" Our methodology can be applied to any EMR data set to reveal co-medication effects of any drug pairs" /><sentence text=" " /></document>